Skip to main content
Log in

Early treatment with frovatriptan can reduce levels of depression among women with menstrual migraine,

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Victor T, White RE.Early treatment with frovatriptan for menstrual migraine: improvements in depression and positive outlook domains of the DAPOS compared with patients' usual care. Annals of Neurology 62 (Suppl. 11): 33, 7 Oct 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Early treatment with frovatriptan can reduce levels of depression among women with menstrual migraine,. Pharmacoecon. Outcomes News 542, 10 (2007). https://doi.org/10.2165/00151234-200705420-00022

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705420-00022

Keywords

Navigation